Figure 10.
In vivo anti-relapse efficacy after imitative breast-conserving surgery. (A) A schematic showing the establishment of a HER2+ breast tumor relapse model in nude mice and the subsequent in vivo experimental procedure for investigating anti-relapse. (B) Changes in tumor volume of mice receiving the indicated treatments over time. V and V0 indicate the tumor volumes after and before the treatment, respectively. (C) Ex vivo tumor weight on day 28 post-treatment. (D) Tumors imaged by a digital camera. (E) Body weights of mice after the various treatments. Each point represents the mean ±SD; n = 5.